title: Use of cyclosporine with poor initial renal function results in severely diminished renal clearance up to three years following liver transplantation.
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: J L
authors.initials: JL
authors.lastname: Cooper
authors.forename: E
authors.initials: E
authors.lastname: Wahlstrom
authors.forename: J
authors.initials: J
authors.lastname: Anderson
authors.forename: L
authors.initials: L
authors.lastname: Schwerman
authors.forename: J
authors.initials: J
authors.lastname: Poterucha
authors.forename: R A
authors.initials: RA
authors.lastname: Krom
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood / Q000378:metabolism; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007668:Kidney / Q000502:physiology*; D007677:Kidney Function Tests; D016031:Liver Transplantation / Q000379:methods / Q000502:physiology*; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013997:Time Factors
chemical_list: D000959:Antihypertensive Agents; D003524:Cyclosporins; D003404:Creatinine